GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » New Horizon Health Ltd (HKSE:06606) » Definitions » Beneish M-Score

New Horizon Health (HKSE:06606) Beneish M-Score : 0.52 (As of Jun. 06, 2024)


View and export this data going back to 2021. Start your Free Trial

What is New Horizon Health Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score 0.52 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for New Horizon Health's Beneish M-Score or its related term are showing as below:

HKSE:06606' s Beneish M-Score Range Over the Past 10 Years
Min: -6.25   Med: -2.65   Max: 4.98
Current: 0.52

During the past 5 years, the highest Beneish M-Score of New Horizon Health was 4.98. The lowest was -6.25. And the median was -2.65.


New Horizon Health Beneish M-Score Historical Data

The historical data trend for New Horizon Health's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

New Horizon Health Beneish M-Score Chart

New Horizon Health Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22
Beneish M-Score
- - -5.82 -6.25 0.52

New Horizon Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only - -6.25 4.98 0.52 -

Competitive Comparison of New Horizon Health's Beneish M-Score

For the Medical Devices subindustry, New Horizon Health's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


New Horizon Health's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, New Horizon Health's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where New Horizon Health's Beneish M-Score falls into.



New Horizon Health Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of New Horizon Health for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.2103+0.528 * 0.8605+0.404 * 2.0388+0.892 * 3.279+0.115 * 1.0312
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.4971+4.679 * 0.129446-0.327 * 1.8334
=0.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec22) TTM:Last Year (Dec21) TTM:
Total Receivables was HK$652 Mil.
Revenue was HK$854 Mil.
Gross Profit was HK$722 Mil.
Total Current Assets was HK$2,234 Mil.
Total Assets was HK$2,875 Mil.
Property, Plant and Equipment(Net PPE) was HK$162 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$29 Mil.
Selling, General, & Admin. Expense(SGA) was HK$798 Mil.
Total Current Liabilities was HK$254 Mil.
Long-Term Debt & Capital Lease Obligation was HK$251 Mil.
Net Income was HK$-88 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$-461 Mil.
Total Receivables was HK$164 Mil.
Revenue was HK$261 Mil.
Gross Profit was HK$189 Mil.
Total Current Assets was HK$2,521 Mil.
Total Assets was HK$2,882 Mil.
Property, Plant and Equipment(Net PPE) was HK$125 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$24 Mil.
Selling, General, & Admin. Expense(SGA) was HK$490 Mil.
Total Current Liabilities was HK$237 Mil.
Long-Term Debt & Capital Lease Obligation was HK$40 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(652.267 / 854.242) / (164.354 / 260.519)
=0.763562 / 0.630871
=1.2103

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(189.358 / 260.519) / (721.588 / 854.242)
=0.726849 / 0.844711
=0.8605

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (2234.073 + 161.518) / 2875.346) / (1 - (2521.34 + 125.025) / 2882.235)
=0.166851 / 0.081836
=2.0388

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=854.242 / 260.519
=3.279

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(23.6 / (23.6 + 125.025)) / (29.399 / (29.399 + 161.518))
=0.158789 / 0.153988
=1.0312

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(798.086 / 854.242) / (489.671 / 260.519)
=0.934262 / 1.879598
=0.4971

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((251.419 + 253.978) / 2875.346) / ((39.559 + 236.761) / 2882.235)
=0.175769 / 0.09587
=1.8334

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-88.486 - 0 - -460.687) / 2875.346
=0.129446

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

New Horizon Health has a M-score of 0.52 signals that the company is likely to be a manipulator.


New Horizon Health Beneish M-Score Related Terms

Thank you for viewing the detailed overview of New Horizon Health's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


New Horizon Health (HKSE:06606) Business Description

Traded in Other Exchanges
Address
400 Jiang’er Road, 13th Floor, T1 Building, Binjiang District, Zhejiang, Hangzhou, CHN, 310052
New Horizon Health Ltd is engaged in early cancer screening and in-home testing in China. The company has an early detection and cancer screening-focused pipeline of five products and product candidates with an emphasis on colorectal cancer screening. The company focuses on cancer prevention and cure through screening and early detection. It generates maximum revenue from ColoClear and Pupu Tube products.
Executives
Invesco Advisers, Inc. 2102 Investment manager
Chen Yiyou 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Bancasa Holding Limited 2201 Interest of corporation controlled by you
Mst Development Limited 2101 Beneficial owner
Yao Naxin 2305 Beneficiary of a trust
Janus Henderson Group Plc 2102 Investment manager
Jpmorgan Chase & Co. 2106 Person having a security interest in shares
Invesco Developing Markets Fund 2106 Person having a security interest in shares
Zhu Yeqing 2101 Beneficial owner
Qiming Venture Partners V, L.p.
Qiming Gp V, L.p.
Qiming Corporate Gp V, Ltd.
Bei Jing Jun Qi Jia Rui Qi Ye Guan Li You Xian Gong Si 2201 Interest of corporation controlled by you
Jun Lian Zi Ben Guan Li Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you

New Horizon Health (HKSE:06606) Headlines

No Headlines